172 related articles for article (PubMed ID: 33230747)
1. Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.
Straker RJ; Song Y; Sun J; Shannon AB; Cohen LS; Muradova E; Daou H; Krause K; Li S; Frederick DT; Rhodin KE; Brizel DM; Boland GM; Beasley GM; Wuthrick EJ; Sondak VK; Zager JS; Lin A; Lukens JN; Karakousis GC
Ann Surg Oncol; 2021 Jul; 28(7):3512-3521. PubMed ID: 33230747
[TBL] [Abstract][Full Text] [Related]
2. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy.
Bhave P; Hong A; Lo SN; Johnson R; Mangana J; Johnson DB; Dulgar O; Eroglu Z; Yeoh HL; Haydon A; Lodde GC; Livingstone E; Khattak A; Kähler K; Hausschild A; McArthur GA; Menzies AM; Long G; Wang W; Carlino MS
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36889810
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
5. The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies.
Kibel S; Kuehne N; Ribeiro MF; Muniz TP; Ye XY; Spreafico A; Saibil SD; Sun A; Mak DY; Gray D; Jones B; Wong P; Butler MO
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136412
[TBL] [Abstract][Full Text] [Related]
6. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
7. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
[TBL] [Abstract][Full Text] [Related]
9. [Long term results following radiation therapy of locally recurrent and metastatic malignant melanoma].
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Pieritz A; Urban A; Schell H; Hohenberger W; Sauer R
Hautarzt; 1999 Aug; 50(8):572-9. PubMed ID: 10460301
[TBL] [Abstract][Full Text] [Related]
10. Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.
Strom T; Torres-Roca JF; Parekh A; Naghavi AO; Caudell JJ; Oliver DE; Messina JL; Khushalani NI; Zager JS; Sarnaik A; Mulé JJ; Trotti AM; Eschrich SA; Sondak VK; Harrison LB
J Natl Compr Canc Netw; 2017 Apr; 15(4):473-482. PubMed ID: 28404758
[No Abstract] [Full Text] [Related]
11. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
Kim YJ; Song SY; Kim W; Jeong SY; Choi W; Je HU; Lee JS; Choi EK
Anticancer Res; 2017 Aug; 37(8):4239-4246. PubMed ID: 28739713
[TBL] [Abstract][Full Text] [Related]
12. Clinical review of treatment outcomes and patterns of failure with adjuvant radiotherapy in node-positive malignant melanoma.
Keenan LG; O'Sullivan S; Glynn A; Higgins M; Flavin A; Brennan S
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):258-262. PubMed ID: 27667733
[TBL] [Abstract][Full Text] [Related]
13. [Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy].
Seegenschmiedt MH; Keilholz L; Pieritz A; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Strahlenther Onkol; 1999 Sep; 175(9):450-7. PubMed ID: 10518979
[TBL] [Abstract][Full Text] [Related]
14. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden.
Spillane AJ; Pasquali S; Haydu LE; Thompson JF
Ann Surg Oncol; 2014 Jan; 21(1):292-9. PubMed ID: 24052314
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
Yuan GW; Li XG; Li N; Yao HW; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
[No Abstract] [Full Text] [Related]
16. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
[TBL] [Abstract][Full Text] [Related]
17. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated or Conventionally Fractionated Adjuvant Radiotherapy After Regional Lymph Node Dissection for High-Risk Stage III Melanoma.
Holtkamp LHJ; Lo S; Drummond M; Thompson JF; Nieweg OE; Hong AM
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e85-e93. PubMed ID: 35851490
[TBL] [Abstract][Full Text] [Related]
19. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
[TBL] [Abstract][Full Text] [Related]
20. Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020.
Mitra D; Rao PK; Nagarajan P; Bishop AJ; Farooqi AS; Gershenwald JE; Wargo J; Keung EZ; Fisher SB; Amaria RN; Davies MA; Ross MI; Guadagnolo BA
Pract Radiat Oncol; 2022; 12(5):437-445. PubMed ID: 35278716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
